Europe Preclinical Imaging Market - Industry Trends and Forecast to 2032

TABLE OF CONTENTS

1 INTRODUCTION 26

• 1.1 OBJECTIVES OF THE STUDY 26
• 1.2 MARKET DEFINITION 26
• 1.3 OVERVIEW OF THE EUROPE PRECLINICAL IMAGING MARKET 26
• 1.4 CURRENCY AND PRICING 28
• 1.5 LIMITATIONS 28
• 1.6 MARKETS COVERED 28

2 MARKET SEGMENTATION 31

• 2.1 MARKETS COVERED 31
• 2.2 GEOGRAPHICAL SCOPE 32
• 2.3 YEARS CONSIDERED FOR THE STUDY 33
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 34
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
• 2.6 MULTIVARIATE MODELLING 38
• 2.7 PRODUCT SEGMENT LIFELINE CURVE 38
• 2.8 MARKET END USER COVERAGE GRID 39
• 2.9 DBMR MARKET POSITION GRID 40
• 2.10 VENDOR SHARE ANALYSIS 42
• 2.11 SECONDARY SOURCES 43
• 2.12 ASSUMPTIONS 43

3 EXECUTIVE SUMMARY 44

4 PREMIUM INSIGHTS 47

• 4.1 PESTEL ANALYSIS 48
• 4.2 PORTER'S FIVE FORCES 49
• 4.3 STRATEGIC INITIATIVES 50

5 REGULATORY FRAMEWORK 51

• 5.1 REGULATORY SCENARIO IN U.S. 51
• 5.2 REGULATORY SCENARIO IN AUSTRALIA 51
• 5.3 REGULATORY SCENARIO IN EUROPE 52
• 5.4 REGULATORY SCENARIO IN SOUTH AFRICA 52
• 5.5 REGULATORY SCENARIO IN BRAZIL 53 

6 MARKET OVERVIEW 54

• 6.1 DRIVERS 56
  • 6.1.1 INCREASING TECHNOLOGY ADVANCEMENT IN THE FIELD OF IMAGING 56
  • 6.1.2 INCREASING NUMBER OF INVESTMENTS AND FUNDING IN RESEARCH AND DEVELOPMENT 56
  • 6.1.3 INCREASING INCIDENCE OF CHRONIC DISEASES 57
• 6.2 RESTRAINTS 58
  • 6.2.1 STRINGENT REGULATORY FRAMEWORK FOR PRODUCT APPROVAL 58
  • 6.2.2 HIGH INSTALLATION AND OPERATIONAL COST OF PRECLINICAL IMAGING SYSTEMS 58
• 6.3 OPPORTUNITIES 59
  • 6.3.1 INCREASING ADOPTION OF IMAGING SYSTEMS FOR PRECLINICAL PURPOSE 59
  • 6.3.2 GROWING DEMAND FOR NON-INVASIVE SMALL-ANIMAL IMAGING METHODS 59
• 6.4 CHALLENGES 60
  • 6.4.1 LACK OF SKILLED PROFESSIONALS FOR THE EFFECTIVE UTILIZATION OF PRECLINICAL IMAGING SYSTEMS 60
  • 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 61

7 EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT 62

• 7.1 OVERVIEW 63
• 7.2 SYSTEMS 64
  • 7.2.1 OPTICAL IMAGING SYSTEMS 65
    • 7.2.1.1 BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS 66
    • 7.2.1.2 STANDALONE FLUORESCENCE IMAGING SYSTEMS 66
    • 7.2.1.3 OPTICAL + X-RAY/OPTICAL + CT 66
  • 7.2.2 PRECLINICAL NUCLEAR IMAGING SYSTEMS 66
    • 7.2.2.1 MICRO-POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS 66
    • 7.2.2.2 MICRO-SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SYSTEMS 66
    • 7.2.2.3 TRIPRODUCT (SPECT/PET/CT) SYSTEMS 67
  • 7.2.3 MICRO-MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 67
  • 7.2.4 MICRO-COMPUTED TOMOGRAPHY (CT) SYSTEMS 67
  • 7.2.5 MICRO-ULTRASOUND SYSTEMS 67
  • 7.2.6 PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS 67
  • 7.2.7 PRECLINICAL MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS 67
  • 7.2.8 MAGNETIC RESONANCE SPECTROSCOPY IMAGING (MRSI) 67
• 7.3 SERVICES 68

8 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS 69

• 8.1 OVERVIEW 70
• 8.2 PRECLINICAL OPTICAL IMAGING REAGENTS 71
  • 8.2.1 BIOLUMINESCENT IMAGING REAGENTS 72
  • 8.2.2 FLUORESCENT IMAGING REAGENTS 72
• 8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS 72
  • 8.3.1 PRECLINICAL PET TRACERS 73
  • 8.3.2 PRECLINICAL SPECT PROBES 73
• 8.4 PRECLINICAL MRI CONTRAST AGENTS 73
  • 8.4.1 GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS 74
  • 8.4.2 MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS 74
  • 8.4.3 IRON-BASED PRECLINICAL MRI CONTRAST AGENTS 74
• 8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS 74
• 8.6 PRECLINICAL CT CONTRAST AGENTS 75
  • 8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS 75
  • 8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS 75
  • 8.6.3 GOLD NANOPARTICLES 76
  • 8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS 76

9 EUROPE PRECLINICAL IMAGING MARKET, BY APPLICATION 77

• 9.1 OVERVIEW 78
• 9.2 RESEARCH AND DEVELOPMENT 79
• 9.3 DRUG DISCOVERY 80
• 9.4 BIO-DISTRIBUTION 80
• 9.5 CANCER CELL DETECTION 81
• 9.6 BIO-MARKERS 81
• 9.7 OTHERS 82

10 EUROPE PRECLINICAL IMAGING MARKET, BY END USER 83

• 10.1 OVERVIEW 84
• 10.2 CONTRACT RESEARCH ORGANIZATION 85
• 10.3 PHARMACEUTICAL & BIOTECH COMPANIES 86
• 10.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 86
• 10.5 DIAGNOSTICS CENTER 87
• 10.6 OTHERS 87

11 EUROPE PRECLINICAL IMAGING MARKET, BY REGION 88

• 11.1 EUROPE 89
  • 11.1.1 GERMANY 96
  • 11.1.2 FRANCE 105
  • 11.1.3 U.K. 114
  • 11.1.4 ITALY 123
  • 11.1.5 SPAIN 132
  • 11.1.6 RUSSIA 141
  • 11.1.7 TURKEY 150
  • 11.1.8 BELGIUM 159
  • 11.1.9 NETHERLANDS 169
  • 11.1.10 SWITZERLANDS 177
  • 11.1.11 REST OF EUROPE 187

12 EUROPE PRECLINICAL IMAGING MARKET, COMPANY LANDSCAPE 188

• 12.1 COMPANY SHARE ANALYSIS: EUROPE 188

13 SWOT ANALYSIS 189

14 COMPANY PROFILE 190

• 14.1 PERKINELMER INC. 190
  • 14.1.1 COMPANY SNAPSHOT 190
  • 14.1.2 REVENUE ANALYSIS 190
  • 14.1.3 COMPANY SHARE ANALYSIS 191
  • 14.1.4 PRODUCT PORTFOLIO 191
  • 14.1.5 RECENT DEVELOPMENT 192
• 14.2 FUJIFILM VISUALSONICS, INC 193
  • 14.2.1 COMPANY SNAPSHOT 193
  • 14.2.2 REVENUE ANALYSIS 193
  • 14.2.3 COMPANY SHARE ANALYSIS 194
  • 14.2.4 PRODUCT PORTFOLIO 194
  • 14.2.5 RECENT DEVELOPMENT 194
• 14.3 BRUKER 195
  • 14.3.1 COMPANY SNAPSHOT 195
  • 14.3.2 REVENUE ANALYSIS 195
  • 14.3.3 COMPANY SHARE ANALYSIS 196
  • 14.3.4 PRODUCT PORTFOLIO 196
  • 14.3.5 RECENT DEVELOPMENT 196 
• 14.4 HOLOGIC, INC. 197
  • 14.4.1 COMPANY SNAPSHOT 197
  • 14.4.2 REVENUE ANALYSIS 197
  • 14.4.3 COMPANY SHARE ANALYSIS 198
  • 14.4.4 PRODUCT PORTFOLIO 198
  • 14.4.5 RECENT DEVELOPMENT 198
• 14.5 ZEISS INTERNATIONAL 199
  • 14.5.1 COMPANY SNAPSHOT 199
  • 14.5.2 REVENUE ANALYSIS 199
  • 14.5.3 COMPANY SHARE ANALYSIS 200
  • 14.5.4 PRODUCT PORTFOLIO 200
  • 14.5.5 RECENT DEVELOPMENTS 200
• 14.6 ADVANCED MOLECULAR VISION, INC. 201
  • 14.6.1 COMPANY SNAPSHOT 201
  • 14.6.2 PRODUCT PORTFOLIO 201
  • 14.6.3 RECENT DEVELOPMENTS 201
• 14.7 AGILENT TECHNOLOGIES, INC. 202
  • 14.7.1 COMPANY SNAPSHOT 202
  • 14.7.2 REVENUE ANALYSIS 202
  • 14.7.3 PRODUCT PORTFOLIO 203
  • 14.7.4 RECENT DEVELOPMENT 203
• 14.8 AI4R 204
  • 14.8.1 COMPANY SNAPSHOT 204
  • 14.8.2 PRODUCT PORTFOLIO 204
  • 14.8.3 RECENT DEVELOPMENT 204
• 14.9 ASPECT IMAGING LTD. 205
  • 14.9.1 COMPANY SNAPSHOT 205
  • 14.9.2 PRODUCT PORTFOLIO 205
  • 14.9.3 RECENT DEVELOPMENT 205
• 14.10 BERTHOLD TECHNOLOGIES GMBH & CO.KG 206
  • 14.10.1 COMPANY SNAPSHOT 206
  • 14.10.2 PRODUCT PORTFOLIO 206
  • 14.10.3 RECENT DEVELOPMENT 206
• 14.11 CUBRESA INC. 207
  • 14.11.1 COMPANY SNAPSHOT 207
  • 14.11.2 PRODUCT PORTFOLIO 207
  • 14.11.3 RECENT DEVELOPMENT 207 
• 14.12 HAMAMATSU PHOTONICS K.K. 208
  • 14.12.1 COMPANY SNAPSHOT 208
  • 14.12.2 REVENUE ANALYSIS 208
  • 14.12.3 PRODUCT PORTFOLIO 209
  • 14.12.4 RECENT DEVELOPMENT 209
• 14.13 IVIM TECHNOLOGY CORP. 210
  • 14.13.1 COMPANY SNAPSHOT 210
  • 14.13.2 PRODUCT PORTFOLIO 210
  • 14.13.3 RECENT DEVELOPMENT 210
• 14.14 KUB TECHNOLOGES INC. 212
  • 14.14.1 COMPANY SNAPSHOT 212
  • 14.14.2 PRODUCT PORTFOLIO 212
  • 14.14.3 RECENT DEVELOPMENT 212
• 14.15 LI-COR, INC. 213
  • 14.15.1 COMPANY SNAPSHOT 213
  • 14.15.2 PRODUCT PORTFOLIO 213
  • 14.15.3 RECENT DEVELOPMENT 213
• 14.16 MEDISO LTD. 214
  • 14.16.1 COMPANY SNAPSHOT 214
  • 14.16.2 PRODUCT PORTFOLIO 214
  • 14.16.3 RECENT DEVELOPMENT 214
• 14.17 MILABS B.V. 215
  • 14.17.1 COMPANY SNAPSHOT 215
  • 14.17.2 PRODUCT PORTFOLIO 215
  • 14.17.3 RECENT DEVELOPMENT 215
• 14.18 MR SOLUTIONS 216
  • 14.18.1 COMPANY SNAPSHOT 216
  • 14.18.2 PRODUCT PORTFOLIO 216
  • 14.18.3 RECENT DEVELOPMENT 216
• 14.19 PHOTON ETC 217
  • 14.19.1 COMPANY SNAPSHOT 217
  • 14.19.2 PRODUCT PORTFOLIO 217
  • 14.19.3 RECENT DEVELOPMENT 217
• 14.20 SOFIE 218
  • 14.20.1 COMPANY SNAPSHOT 218
  • 14.20.2 PRODUCT PORTFOLIO 218
  • 14.20.3 RECENT DEVELOPMENT 218 
• 14.21 TRIFOIL IMAGING 219
  • 14.21.1 COMPANY SNAPSHOT 219
  • 14.21.2 PRODUCT PORTFOLIO 219
  • 14.21.3 RECENT DEVELOPMENT 219
• 14.22 VIEWORKS CO., LTD. 220
  • 14.22.1 COMPANY SNAPSHOT 220
  • 14.22.2 REVENUE ANALYSIS 220
  • 14.22.3 PRODUCT PORTFOLIO 221
  • 14.22.4 RECENT DEVELOPMENT 221

15 QUESTIONNAIRE 222

16 RELATED REPORTS 225

LIST OF TABLES

• TABLE 1 EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 64
• TABLE 2 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
• TABLE 3 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 65
• TABLE 4 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 65
• TABLE 5 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 66
• TABLE 6 EUROPE SERVICES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
• TABLE 7 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 71
• TABLE 8 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
• TABLE 9 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 72
• TABLE 10 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
• TABLE 11 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 73
• TABLE 12 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
• TABLE 13 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 74
• TABLE 14 EUROPE PRECLINICAL ULTRASOUND CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
• TABLE 15 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
• TABLE 16 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 75
• TABLE 17 EUROPE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 79
• TABLE 18 EUROPE RESEARCH AND DEVELOPMENT IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
• TABLE 19 EUROPE DRUG DISCOVERY IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
• TABLE 20 EUROPE BIO-DISTRIBUTION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
• TABLE 21 EUROPE CANCER CELL DETECTION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
• TABLE 22 EUROPE BIO-MARKERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
• TABLE 23 EUROPE OTHERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
• TABLE 24 EUROPE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 85
• TABLE 25 EUROPE CONTRACT RESEARCH ORGANIZATION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
• TABLE 26 EUROPE PHARMACEUTICAL & BIOTECH COMPANIES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
• TABLE 27 EUROPE ACADEMIC & GOVERNMENT RESEARCH INSTITUTES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
• TABLE 28 EUROPE DIAGNOSTICS CENTER IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
• TABLE 29 EUROPE OTHERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
• TABLE 30 EUROPE PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 89
• TABLE 31 EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 90
• TABLE 32 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 90
• TABLE 33 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 91
• TABLE 34 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 91
• TABLE 35 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 91
• TABLE 36 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 92
• TABLE 37 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 92
• TABLE 38 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 92
• TABLE 39 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 93
• TABLE 40 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 93
• TABLE 41 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 93
• TABLE 42 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 94
• TABLE 43 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 94
• TABLE 44 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 94
• TABLE 45 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 95
• TABLE 46 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 95
• TABLE 47 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 95
• TABLE 48 EUROPE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 96
• TABLE 49 EUROPE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 96
• TABLE 50 GERMANY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 97
• TABLE 51 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 97
• TABLE 52 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 98
• TABLE 53 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 98
• TABLE 54 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 99
• TABLE 55 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 99
• TABLE 56 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 99
• TABLE 57 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 100
• TABLE 58 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 100
• TABLE 59 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 100
• TABLE 60 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 101
• TABLE 61 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 101
• TABLE 62 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 101
• TABLE 63 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 102
• TABLE 64 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 102
• TABLE 65 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 102
• TABLE 66 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 102
• TABLE 67 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 103
• TABLE 68 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 103
• TABLE 69 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 103
• TABLE 70 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 103
• TABLE 71 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 104
• TABLE 72 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 104
• TABLE 73 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 104
• TABLE 74 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 105
• TABLE 75 GERMANY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 105
• TABLE 76 GERMANY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 105
• TABLE 77 FRANCE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 106
• TABLE 78 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 106
• TABLE 79 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 107
• TABLE 80 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 107
• TABLE 81 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 108
• TABLE 82 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 108
• TABLE 83 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 108
• TABLE 84 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 108
• TABLE 85 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 109
• TABLE 86 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 109
• TABLE 87 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 109
• TABLE 88 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 110
• TABLE 89 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 110
• TABLE 90 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 110
• TABLE 91 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 110
• TABLE 92 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 111
• TABLE 93 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 111
• TABLE 94 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 111
• TABLE 95 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 111
• TABLE 96 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 112
• TABLE 97 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 112
• TABLE 98 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 112
• TABLE 99 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 113
• TABLE 100 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 113
• TABLE 101 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 113
• TABLE 102 FRANCE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 114
• TABLE 103 FRANCE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 114
• TABLE 104 U.K. PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 115
• TABLE 105 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 115
• TABLE 106 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 116
• TABLE 107 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 116
• TABLE 108 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 117
• TABLE 109 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 117
• TABLE 110 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 117
• TABLE 111 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 117
• TABLE 112 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 118
• TABLE 113 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 118
• TABLE 114 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 118
• TABLE 115 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 119
• TABLE 116 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 119
• TABLE 117 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 119
• TABLE 118 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 119
• TABLE 119 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 120
• TABLE 120 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 120
• TABLE 121 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 120
• TABLE 122 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 120
• TABLE 123 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 121
• TABLE 124 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 121
• TABLE 125 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 121
• TABLE 126 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 122
• TABLE 127 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 122
• TABLE 128 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 122
• TABLE 129 U.K. PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
• TABLE 130 U.K. PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 123
• TABLE 131 ITALY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 124
• TABLE 132 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 124
• TABLE 133 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 125
• TABLE 134 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 125
• TABLE 135 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 126
• TABLE 136 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 126
• TABLE 137 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 126
• TABLE 138 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 127
• TABLE 139 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 127
• TABLE 140 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 127
• TABLE 141 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 128
• TABLE 142 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 128
• TABLE 143 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 128
• TABLE 144 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 129
• TABLE 145 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 129
• TABLE 146 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 129
• TABLE 147 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 129
• TABLE 148 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 130
• TABLE 149 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 130
• TABLE 150 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 130
• TABLE 151 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 130
• TABLE 152 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 131
• TABLE 153 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 131
• TABLE 154 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 131
• TABLE 155 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 132
• TABLE 156 ITALY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
• TABLE 157 ITALY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
• TABLE 158 SPAIN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 133
• TABLE 159 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 133
• TABLE 160 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 134
• TABLE 161 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 134
• TABLE 162 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 135
• TABLE 163 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 135
• TABLE 164 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 135
• TABLE 165 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 136
• TABLE 166 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 136
• TABLE 167 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 136

• TABLE 168 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 137
• TABLE 169 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 137
• TABLE 170 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 137
• TABLE 171 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 138
• TABLE 172 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 138
• TABLE 173 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 138
• TABLE 174 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 138
• TABLE 175 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 139
• TABLE 176 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 139
• TABLE 177 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 139
• TABLE 178 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 139
• TABLE 179 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 140
• TABLE 180 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 140
• TABLE 181 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 140
• TABLE 182 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 141
• TABLE 183 SPAIN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 141
• TABLE 184 SPAIN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 141
• TABLE 185 RUSSIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
• TABLE 186 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
• TABLE 187 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 143
• TABLE 188 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 143
• TABLE 189 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 144
• TABLE 190 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 144
• TABLE 191 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 144
• TABLE 192 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 144
• TABLE 193 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 145
• TABLE 194 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 145
• TABLE 195 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 145
• TABLE 196 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 146
• TABLE 197 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 146
• TABLE 198 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 146
• TABLE 199 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 146
• TABLE 200 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 147
• TABLE 201 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 147
• TABLE 202 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 147
• TABLE 203 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 147
• TABLE 204 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 148
• TABLE 205 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 148
• TABLE 206 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 148
• TABLE 207 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 149
• TABLE 208 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 149
• TABLE 209 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 149
• TABLE 210 RUSSIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 150
• TABLE 211 RUSSIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
• TABLE 212 TURKEY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
• TABLE 213 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
• TABLE 214 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 152
• TABLE 215 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 152
• TABLE 216 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 153
• TABLE 217 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 153
• TABLE 218 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 153
• TABLE 219 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 153
• TABLE 220 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 154
• TABLE 221 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 154
• TABLE 222 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 154
• TABLE 223 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 155
• TABLE 224 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 155
• TABLE 225 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 155
• TABLE 226 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 156
• TABLE 227 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 156
• TABLE 228 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 156
• TABLE 229 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 156
• TABLE 230 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 156
• TABLE 231 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 157
• TABLE 232 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 157
• TABLE 233 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 157
• TABLE 234 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 158
• TABLE 235 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 158
• TABLE 236 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 158
• TABLE 237 TURKEY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 159
• TABLE 238 TURKEY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 159
• TABLE 239 BELGIUM PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 160
• TABLE 240 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 160
• TABLE 241 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 161
• TABLE 242 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 161
• TABLE 243 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 162
• TABLE 244 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 162
• TABLE 245 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 162
• TABLE 246 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 162
• TABLE 247 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 163
• TABLE 248 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 163
• TABLE 249 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 163
• TABLE 250 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 164
• TABLE 251 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 164
• TABLE 252 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 164
• TABLE 253 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 164
• TABLE 254 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 165
• TABLE 255 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 165
• TABLE 256 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 165
• TABLE 257 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 165
• TABLE 258 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 166
• TABLE 259 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 166
• TABLE 260 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 166
• TABLE 261 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 167
• TABLE 262 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 167
• TABLE 263 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 167
• TABLE 264 BELGIUM PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 168
• TABLE 265 BELGIUM PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 168
• TABLE 266 NETHERLANDS PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 169
• TABLE 267 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 169
• TABLE 268 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 170
• TABLE 269 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 170
• TABLE 270 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 171
• TABLE 271 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 171
• TABLE 272 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 171
• TABLE 273 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 171
• TABLE 274 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 172
• TABLE 275 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 172
• TABLE 276 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 172
• TABLE 277 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 173
• TABLE 278 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 173
• TABLE 279 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 173
• TABLE 280 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 173
• TABLE 281 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 174
• TABLE 282 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 174
• TABLE 283 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 174
• TABLE 284 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 174
• TABLE 285 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 175
• TABLE 286 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 175
• TABLE 287 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 175
• TABLE 288 NETHERLANDS PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 176
• TABLE 289 NETHERLANDS PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 176
• TABLE 290 NETHERLANDS PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 177
• TABLE 291 NETHERLANDS PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 177
• TABLE 292 SWITZERLAND PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 177
• TABLE 293 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 179
• TABLE 294 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 179
• TABLE 295 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 180
• TABLE 296 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 180
• TABLE 297 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 180
• TABLE 298 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 181
• TABLE 299 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 181
• TABLE 300 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 181
• TABLE 301 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 182
• TABLE 302 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 182
• TABLE 303 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 182
• TABLE 304 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 183
• TABLE 305 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 183
• TABLE 306 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 183
• TABLE 307 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 183
• TABLE 308 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 184
• TABLE 309 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 184
• TABLE 310 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 184
• TABLE 311 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 184
• TABLE 312 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 185
• TABLE 313 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 185
• TABLE 314 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 185
• TABLE 315 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 186
• TABLE 316 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 186
• TABLE 317 SWITZERLAND PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 186
• TABLE 318 SWITZERLAND PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 187
• TABLE 319 REST OF EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 187

LIST OF FIGURES

• FIGURE 1 EUROPE PRECLINICAL IMAGING MARKET: SEGMENTATION 31
• FIGURE 2 EUROPE PRECLINICAL IMAGING MARKET: DATA TRIANGULATION 34
• FIGURE 3 EUROPE PRECLINICAL IMAGING MARKET: DROC ANALYSIS 35
• FIGURE 4 EUROPE PRECLINICAL IMAGING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 36
• FIGURE 5 EUROPE PRECLINICAL IMAGING MARKET: COMPANY RESEARCH ANALYSIS 36
• FIGURE 6 EUROPE PRECLINICAL IMAGING MARKET: INTERVIEW DEMOGRAPHICS 37
• FIGURE 7 EUROPE PRECLINICAL IMAGING MARKET: MARKET END USERS COVERAGE GRID 39
• FIGURE 8 EUROPE PRECLINICAL IMAGING MARKET: DBMR MARKET POSITION GRID 40
• FIGURE 9 EUROPE PRECLINICAL IMAGING MARKET: VENDOR SHARE ANALYSIS 42
• FIGURE 10 EUROPE PRECLINICAL IMAGING MARKET: SEGMENTATION 46
• FIGURE 11 RISING PREVALENCE OF CHRONIC DISORDER AND ADVANCEMENTS IN IMAGING TECHNIQUES ARE EXPECTED TO DRIVE THE GROWTH OF THE EUROPE PRECLINICAL IMAGING MARKET FROM 2023 TO 2030 47
• FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PRECLINICAL MARKET IN 2023 AND 2030 47
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE PRECLINICAL IMAGING MARKET 55
• FIGURE 14 EUROPE PRECLINICAL IMAGING MARKET: BY PRODUCT, 2022 63
• FIGURE 15 EUROPE PRECLINICAL IMAGING MARKET: BY REAGENTS, 2022 70
• FIGURE 16 EUROPE PRECLINICAL IMAGING MARKET: BY APPLICATION, 2022 78
• FIGURE 17 EUROPE PRECLINICAL IMAGING MARKET: BY END USER, 2022 84
• FIGURE 18 EUROPE PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 188